Background Gamma Knife radiosurgery (GKRS) has been demonstrated to be an effective and safe treatment method for dural arteriovenous fistulas (DAVFs). However, only few studies, mostly with limited patient numbers, have evaluated radiosurgery as a sole and upfront treatment option for DAVFs.
Methods Thirty-three DAVF patients treated with GKRS as a stand-alone management at our institution between January 1992 and January 2020 were included in this study. Obliteration rates, time to obliteration, neurologic outcome, and complications were evaluated retrospectively.
Results Complete overall obliteration was achieved in 20/28 (71%) patients. The postradiosurgery actuarial rates of obliteration at 2, 5, and 10 years were 53, 71, and 85%, respectively. No difference in time to obliteration between carotid–cavernous fistulas (CCFs; 14/28, 50%, 17 months; 95% confidence interval [CI]: 7.4–27.2) and non-CCFs (NCCFs; 14/28, 50%, 37 months; 95% CI: 34.7–38.5; p = 0.111) were found. Overall, the neurologic outcome in our series was highly favorable at the time of the last follow-up. A complete resolution of symptoms was seen in two-thirds (20/30, 67%) of patients. One patient with multiple DAVFs suffered from an intracranial hemorrhage of the untreated lesion and died during the follow-up period, resulting in a yearly bleeding risk of 0.5%. No complications after radiosurgery were observed in our series.
Conclusion Our results show that GKRS is a safe and effective stand-alone management option for selected DAVF patients.
<p align="right">J Neurol Surg A Cent Eur Neurosurg<br/>DOI: 10.1055/a-2235-5256</p><p>
Background Gamma Knife radiosurgery (GKRS) has been demonstrated to be an effective and safe treatment method for dural arteriovenous fistulas (DAVFs). However, only few studies, mostly with limited patient numbers, have evaluated radiosurgery as a sole and upfront treatment option for DAVFs.
Methods Thirty-three DAVF patients treated with GKRS as a stand-alone management at our institution between January 1992 and January 2020 were included in this study. Obliteration rates, time to obliteration, neurologic outcome, and complications were evaluated retrospectively.
Results Complete overall obliteration was achieved in 20/28 (71%) patients. The postradiosurgery actuarial rates of obliteration at 2, 5, and 10 years were 53, 71, and 85%, respectively. No difference in time to obliteration between carotid–cavernous fistulas (CCFs; 14/28, 50%, 17 months; 95% confidence interval [CI]: 7.4–27.2) and non-CCFs (NCCFs; 14/28, 50%, 37 months; 95% CI: 34.7–38.5; p = 0.111) were found. Overall, the neurologic outcome in our series was highly favorable at the time of the last follow-up. A complete resolution of symptoms was seen in two-thirds (20/30, 67%) of patients. One patient with multiple DAVFs suffered from an intracranial hemorrhage of the untreated lesion and died during the follow-up period, resulting in a yearly bleeding risk of 0.5%. No complications after radiosurgery were observed in our series.
Conclusion Our results show that GKRS is a safe and effective stand-alone management option for selected DAVF patients.<br/><a href="/DOI/DOI?10.1055/a-2235-5256">[...]</a><br/><br/></p><p>Georg Thieme Verlag KG Rüdigerstraße 14, 70469 Stuttgart, Germany</p><p>Article in Thieme eJournals:<br/><a href="https://www.thieme-connect.com/products/ejournals/issue/eFirst/10.1055/s-00000180">Table of contents</a> | <a href="https://www.thieme-connect.com/products/ejournals/abstract/10.1055/a-2235-5256">Abstract</a> | <a href="https://www.thieme-connect.com/products/ejournals/html/10.1055/a-2235-5256">Full text</a></p>